Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.
By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.
You're browsing as a guest. Some features like watchlists and alerts require a free account.

Centene Corporation
| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 5d | CNC | 8-K | Centene Corporation to Discuss Financial Guidance at Deutsche Bank 2026 Healthcare Summit | — | — | — |
| 08/17 | CNC | 8-K | Centene Appoints New CFO Chris Neczypor | — | — | — |
| 07/29 | CNC | 8-K | Centene Corporation Announces Partial Redemption of 4.25% Notes Due 2027 | — | — | — |
| 07/27 | CNC | 8-K | Centene Reports Q2 2026 Financial Results and Board Changes | — | — | — |
| 06/22 | CNC | 8-K | Centene Appoints Lauren M. Tyler to Board of Directors | — | — | — |
| 05/15 | CNC | 8-K | Centene Corporation Annual Meeting Results and Executive Appointments | — | — | — |
| 04/27 | CNC | 8-K | Centene Corporation Reports Strong Q1 2026 Results and Updates Guidance | — | — | — |
| 03/24 | CNC | 8-K | Centene Appoints New Chief Accounting Officer | — | — | — |
| 03/09 | CNC | 8-K | Centene Announces Redemption of $1 Billion in 2027 Notes | — | — | — |
| 02/20 | CNC | 8-K | Centene Reaffirms 2026 Earnings Guidance | — | — | — |
| 02/05 | CNC | 8-K | Centene Reports 2025 Results and Provides 2026 Guidance | — | — | — |
| 11/10/25 | CNC | 8-K | Centene to Discuss Financial Outlook at UBS 2025 Global Healthcare Conference | — | — | — |
| 10/28/25 | CNC | 8-K | Centene Reports Q3 2025 Financial Results | — | — | — |
| 09/10/25 | CNC | 8-K | Centene Corporation to Discuss Financial Results at Deutsche Bank Healthcare Summit | — | — | — |
| 08/15/25 | CNC | 8-K | Board Member Thomas R. Greco Resigns from Centene Corporation | — | — | — |
| 08/04/25 | CNC | 8-K | Immediate Resignation of Director Wayne S. DeVeydt from Centene Corporation | — | — | — |
| 07/25/25 | CNC | 8-K | Centene Corporation Reports Second Quarter 2025 Financial Results | — | — | — |
| 07/01/25 | CNC | 8-K | Centene Corporation Withdraws 2025 Earnings Guidance | — | — | — |
| 05/14/25 | CNC | 8-K | Centene Corporation Holds Annual Meeting and Votes on Key Proposals | — | — | — |
| 05/06/25 | CNC | 8-K | Centene Corporation Reaffirms 2025 Earnings Guidance | — | — | — |
| 04/25/25 | CNC | 8-K | Centene Reports Strong Q1 2025 Earnings and Raises Guidance | — | — | — |
| 03/12/25 | CNC | 8-K | Centene Reaffirms 2025 Earnings Guidance at Barclays Conference | — | — | — |
| 03/05/25 | CNC | 8-K | Centene Corporation Enters into New Credit Agreement | — | — | — |
| 03/03/25 | CNC | 8-K | Centene Corporation Reaffirms 2025 EPS Guidance | — | — | — |
| 02/24/25 | CNC | 8-K | Centene Appoints Kenneth Y. Tanji to Board of Directors | — | — | — |
| 02/04/25 | CNC | 8-K | Centene Reports 2024 Financial Results and Membership Growth | — | — | — |
| 12/12/24 | CNC | 8-K | Centene Corporation Reaffirms 2024 Guidance and Provides 2025 Financial Outlook | — | — | — |
| 11/13/24 | CNC | 8-K | Centene Corporation Announces Investor Meeting and Reaffirms 2024 Earnings Guidance | — | — | — |
| 11/12/24 | CNC | 8-K | Kenneth J. Fasola to Retire as President of Centene Corporation | — | — | — |
| 10/25/24 | CNC | 8-K | Centene Reports Q3 2024 Financial Results | — | — | — |
| 10/11/24 | CNC | 8-K | Centene Announces Improvement in Medicare Advantage Star Ratings | — | — | — |
| 10/03/24 | CNC | 8-K | Board Committee Appointments for New Director | — | — | — |
| 09/27/24 | CNC | 8-K | Centene Corporation Announces Departure of Director Lori J. Robinson | — | — | — |
| 09/16/24 | CNC | 8-K | Centene Corporation to Reaffirm 2024 Earnings Guidance at Upcoming Investor Meetings | — | — | — |
| 09/10/24 | CNC | 8-K | Centene Reaffirms 2024 EPS Guidance and Shifts Q4 Performance | — | — | — |
| 08/15/24 | CNC | 8-K | Centene Appoints Thomas Greco to Board of Directors | — | — | — |
| 07/26/24 | CNC | 8-K | Centene Corporation Reports Second Quarter 2024 Results | — | — | — |
| 07/23/24 | CNC | 8-K | Centene Announces Preliminary Q2 2024 Financial Results | — | — | — |
| 05/29/24 | CNC | 8-K | Centene Reaffirms 2024 Guidance and Discloses Conference Presentation Details | — | — | — |
| 05/16/24 | CNC | 8-K | Centene Corporation Annual Meeting Voting Results | — | — | — |
| 04/26/24 | CNC | 8-K | Centene Corporation Announces Q1 2024 Results and Raises Guidance | — | — | — |
| 03/29/24 | CNC | 8-K | James E. Murray Retires from Centene Corporation | — | — | — |
| 03/11/24 | CNC | 8-K | Centene Corporation to Reaffirm 2024 Earnings Guidance at Barclays Healthcare Conference | — | — | — |
| 02/06/24 | CNC | 8-K | Centene Reports 2023 Earnings with Adjusted EPS of $6.68 | — | — | — |
Centene Corporation (CNC): 44 8-K filings summarized, the most recent on Sep 15, 2026.
Centene Corporation announced its participation in the Deutsche Bank 2026 Healthcare Summit on September 16, 2026, where management will discuss the company's business and financial results. The company reaffirmed its full-year 2026 GAAP diluted earnings per share (EPS) guidance of greater than $3.11 and its full-year…
Centene Corporation to Discuss Financial Guidance at Deutsche Bank 2026 Healthcare SummitCentene Corporation announced that its current Chief Financial Officer (CFO), Andrew Asher, will retire at the end of 2027 after stepping down from his CFO role on December 31, 2026. Chris Neczypor, previously CFO of Lincoln National Corporation, will succeed Asher as Centene's CFO, effective January 1, 2027. Neczypor…
Centene Appoints New CFO Chris NeczyporOn July 29, 2026, Centene Corporation announced the partial redemption of $500,000,000 aggregate principal amount of its outstanding 4.25% Notes due December 15, 2027. The redemption is scheduled for August 13, 2026, and will leave approximately $568,664,000 of the 2027 Notes outstanding. The redemption price includes…
Centene Corporation Announces Partial Redemption of 4.25% Notes Due 2027Centene Corporation announced its financial results for the second quarter of 2026, reporting GAAP diluted earnings per share of $2.19 and adjusted diluted earnings per share of $2.51. The company also increased its full-year 2026 guidance for GAAP diluted EPS to greater than $3.11 and for adjusted diluted EPS to…
Centene Reports Q2 2026 Financial Results and Board ChangesCentene Corporation announced the appointment of Lauren M. Tyler to its Board of Directors, effective June 19, 2026. Ms. Tyler, with over 30 years of leadership experience in various sectors, will serve on the Audit Committee and the Compensation and Talent Committee. Her extensive background includes senior roles at…
Centene Appoints Lauren M. Tyler to Board of Directors